※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
기관절개 튜브 시장 성장과 동향:
Grand View Research, Inc.의 최신 보고서에 따르면 세계 기관 절개 튜브 시장 규모는 2030년까지 1억 3,670만 달러에 달할 것으로 예상되며, 2024년부터 2030년까지 연평균 4.2%의 CAGR을 기록할 것으로 예상됩니다.
이 시장은 만성 호흡기 질환의 유병률 증가, 기술 발전, 외과 수술의 증가로 인해 크게 성장하고 있습니다. 노인은 기관절개술이 필요한 호흡기 질환에 걸리기 쉽기 때문에 고령화가 수요를 더욱 촉진하고 있습니다. 예를 들어, 2022년 8월에 발표된 미국 국립생물공학정보센터(NCBI)의 데이터에 따르면 미국인들은 보통 일생 동안 약 9번의 수술을 받습니다. 미국에서는 매년 5,100만 건 이상의 수술이 이루어지고 있으며, 노인이 수술 환자 수의 거의 절반을 차지합니다.
보건의료 인프라가 강화되고, 유리한 상환 정책이 시행되면서 전 세계적으로 기관절개술에 대한 접근성이 향상되고 있습니다. 또한 기관절개술에 대한 인식이 높아지고 전문 교육이 확대되면서 보급률이 증가하고 있습니다. 높은 비용과 잠재적인 합병증 등의 문제에도 불구하고, 지속적인 기술 혁신과 환자 결과 개선에 힘입어 시장은 계속 확대되고 있습니다.
기관절개 튜브 시장 보고서 하이라이트
- 유형별로는 커프스 부문이 2023년 62.7%의 가장 큰 매출 점유율을 차지했으며, 예측 기간 동안 4.3%의 CAGR로 가장 빠르게 성장할 것으로 예상됩니다.
- 인구 통계학에 따르면, 성인 환자 부문은 2023년 71.8%로 가장 큰 매출 비중을 차지했으며, 예측 기간 동안 4.4%의 CAGR로 가장 빠르게 성장할 것으로 예상됩니다.
- 최종 용도에 따라 병원 부문은 2023년 49.4%로 가장 큰 매출 점유율을 차지했으며, 기관절개술의 대부분을 차지하고 이러한 장치가 필요한 환자에게 전문적인 치료와 관리를 제공하기 때문에 예측 기간 동안 4.7%의 가장 빠른 CAGR로 성장할 것으로 예상됩니다.
- 2023년에는 북미가 36.7%의 점유율로 우위를 차지했습니다.이 지역은 높은 수준의 의료 인프라, 높은 호흡기 질환 유병률, 높은 의료비 지출로 인해 주도하고 있기 때문입니다.
목차
제1장 조사 방법과 범위
제2장 주요 요약
제3장 기관절개 튜브 시장 변수, 동향, 범위
- 시장 계통 전망
- 시장 역학
- 시장 성장 촉진요인 분석
- 시장 성장 억제요인 분석
- 기관절개 튜브 시장 분석 툴
- 업계 분석 - Porter's Five Forces 분석
- PESTEL 분석
제4장 기관절개 튜브 시장 : 유형별 추정·동향 분석
- 부문 대시보드
- 기관절개 튜브 시장 : 유형별 변동 분석
- 기관절개 튜브 시장 : 유형별 전망
- 2018년부터 2030년까지 시장 규모와 예측 및 동향 분석
- 수갑
- 수갑 없음
제5장 기관절개 튜브 시장 : 인구통계별 추정·동향 분석
- 부문 대시보드
- 기관절개 튜브 시장 : 인구통계별 변동 분석
- 기관절개 튜브 시장 : 인구통계별 전망
- 2018년부터 2030년까지 시장 규모와 예측 및 동향 분석
- 성인 환자
- 소아·신생아 환자
제6장 기관절개 튜브 시장 : 최종 용도별 추정·동향 분석
- 부문 대시보드
- 기관절개 튜브 시장 : 최종 용도별 변동 분석
- 기관절개 튜브 시장 : 최종 용도별 전망
- 2018년부터 2030년까지 시장 규모와 예측 및 동향 분석
- 병원
- 외래 수술 센터
- 전문 클리닉
제7장 기관절개 튜브 시장 : 지역별 추정·동향 분석
- 지역 대시보드
- 기관절개 튜브 시장 : 지역별 변동 분석
- 기관절개 튜브 시장 : 지역별 추정·동향 분석
- 2018년부터 2030년까지 시장 규모와 예측 및 동향 분석
- 북미
- 북미의 기관절개 튜브 시장 추정과 예측, 2018-2030년
- 미국
- 캐나다
- 멕시코
- 유럽
- 유럽의 기관절개 튜브 시장 추정과 예측, 2018-2030년
- 영국
- 독일
- 프랑스
- 이탈리아
- 스페인
- 덴마크
- 스웨덴
- 노르웨이
- 아시아태평양
- 아시아태평양의 기관절개 튜브 시장 추정과 예측, 2018-2030년
- 일본
- 중국
- 인도
- 한국
- 호주
- 태국
- 라틴아메리카
- 라틴아메리카의 기관절개 튜브 시장 추정과 예측, 2018-2030년
- 브라질
- 아르헨티나
- 중동 및 아프리카
- 중동 및 아프리카의 기관절개 튜브 시장 추정과 예측, 2018-2030년
- 남아프리카공화국
- 사우디아라비아
- 아랍에미리트
- 쿠웨이트
제8장 경쟁 상황
- 시장 진출 기업 분류
- 주요 기업 개요
- Pulmodyne, Inc.
- Smiths Group plc
- Medtronic
- TRACOE Medical GmbH
- Teleflex, Inc.
- TuoRen
- ConvaTec Group
- Boston Medical
- Fisher &Paykel Healthcare Ltd.
- Angioplast
- ICU Medical
ksm 24.08.27
Tracheostomy Tubes Market Growth & Trends:
The global tracheostomy tubes market size is expected to reach USD 136.7 million by 2030, registering a CAGR of 4.2% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market is experiencing significant growth due to rising incidences of chronic respiratory diseases, technological advancements, and an increasing number of surgical procedures. An aging population further drives demand, as older individuals are more prone to respiratory conditions necessitating tracheostomies. For instance, according to National Center for Biotechnology Information (NCBI) data published in August 2022, Americans typically undergo about nine surgeries throughout their lives. Each year, over 51 million surgeries are performed in the U.S., with older adults comprising nearly half of the surgical patient population.
Enhanced healthcare infrastructure and favorable reimbursement policies are improving access to these procedures globally. Additionally, increased awareness and professional training in tracheostomy care are boosting adoption rates. Despite challenges such as high costs and potential complications, the market continues to expand, supported by ongoing innovations and improved patient outcomes.
Tracheostomy Tubes Market Report Highlights:
- Based on the type, the cuffed segment accounted for the largest revenue share of 62.7% in 2023 and is expected to grow at the fastest CAGR of 4.3% during the forecast period, as it prevents aspiration and ensuring a secure airway by sealing the trachea with an inflatable cuff.
- Based on the demographics, adult patients segment accounted for the largest revenue share of 71.8% in 2023 and is expected to grow at the fastest CAGR of 4.4% during the forecast period as they often require tracheostomy tubes for long-term airway management and to facilitate ventilation in cases of severe respiratory conditions.
- Based on the end-use, the hospitals segment accounted for the largest revenue share of 49.4% in 2023 and is expected to grow at the fastest CAGR of 4.7% during the forecast period as it accounts for the majority of tracheostomy procedures and provides specialized care and management for patients requiring these devices.
- In 2023, North America dominated with a share of 36.7% as this region is driven by advanced healthcare infrastructure, high prevalence of respiratory diseases, and significant healthcare expenditure.
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.1.1 Segment Definitions
- 1.1.2. Type
- 1.1.3. Demographics
- 1.1.4. End Use
- 1.1.5. Regional scope
- 1.1.6. Estimates and forecasts timeline
- 1.2. Research Methodology
- 1.3. Information Procurement
- 1.3.1. Purchased database
- 1.3.2. GVR's internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.3.5. Details of primary research
- 1.3.5.1. Data for primary interviews in North America
- 1.3.5.2. Data for primary interviews in Europe
- 1.3.5.3. Data for primary interviews in Asia Pacific
- 1.3.5.4. Data for primary interviews in Latin America
- 1.3.5.5. Data for Primary interviews in MEA
- 1.4. Information or Data Analysis
- 1.4.1. Data analysis models
- 1.5. Market Formulation & Validation
- 1.6. Model Details
- 1.6.1. Commodity flow analysis (Model 1)
- 1.6.2. Approach 1: Commodity flow approach
- 1.6.3. Volume price analysis (Model 2)
- 1.6.4. Approach 2: Volume price analysis
- 1.7. List of Secondary Sources
- 1.8. List of Primary Sources
- 1.9. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Type outlook
- 2.2.2. Demographics outlook
- 2.2.3. End Use outlook
- 2.3. Regional outlook
- 2.4. Competitive Insights
Chapter 3. Tracheostomy Tubes Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.1.1. Increasing surgical procedures
- 3.2.1.2. Rising prevalence of chronic respiratory diseases
- 3.2.1.3. Awareness and education
- 3.2.2. Market Restraint Analysis
- 3.2.2.1. Complications and risks associated with tracheostomy
- 3.2.2.2. Stringent regulatory requirements
- 3.3. Tracheostomy Tubes Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's Five Forces
- 3.3.1.1. Bargaining power of suppliers
- 3.3.1.2. Bargaining power of buyers
- 3.3.1.3. Threat of substitutes
- 3.3.1.4. Threat of new entrants
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Economic landscape
- 3.3.2.3. Social landscape
- 3.3.2.4. Technological landscape
- 3.3.2.5. Environmental landscape
- 3.3.2.6. Legal landscape
Chapter 4. Tracheostomy Tubes Market: Type Estimates & Trend Analysis
- 4.1. Segment Dashboard
- 4.2. Tracheostomy Tubes Market: Type Movement Analysis
- 4.3. Tracheostomy Tubes Market by Type Outlook (USD Million)
- 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 4.5. Cuffed
- 4.5.1. Cuffed Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.6. Uncuffed
- 4.6.1. Uncuffed Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Tracheostomy Tubes Market: Demographics Estimates & Trend Analysis
- 5.1. Segment Dashboard
- 5.2. Tracheostomy Tubes Market: Demographics Movement Analysis
- 5.3. Tracheostomy Tubes Market by Demographics Outlook (USD Million)
- 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 5.5. Adult Patients
- 5.5.1. Adult Patients Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.6. Pediatric/Neonatal Patients
- 5.6.1. Pediatric/Neonatal Patients Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Tracheostomy Tubes Market: End Use Estimates & Trend Analysis
- 6.1. Segment Dashboard
- 6.2. Tracheostomy Tubes Market: End Use Movement Analysis
- 6.3. Tracheostomy Tubes Market by End Use Outlook (USD Million)
- 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 6.5. Hospitals
- 6.5.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.6. Ambulatory Surgical Centers
- 6.6.1. Ambulatory Surgical Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.7. Specialty Clinics
- 6.7.1. Specialty Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Tracheostomy Tubes Market: Regional Estimates & Trend Analysis
- 7.1. Regional Dashboard
- 7.2. Regional Tracheostomy Tubes Market movement analysis
- 7.3. Tracheostomy Tubes Market: Regional Estimates & Trend Analysis by Technology & End Use
- 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 7.5. North America
- 7.5.1. North America Tracheostomy Tubes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.2. U.S.
- 7.5.2.1. Key Country Dynamics
- 7.5.2.2. Competitive Scenario
- 7.5.2.3. Regulatory Framework
- 7.5.2.4. Reimbursement scenario
- 7.5.2.5. U.S. Tracheostomy Tubes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.3. Canada
- 7.5.3.1. Key Country Dynamics
- 7.5.3.2. Competitive Scenario
- 7.5.3.3. Regulatory Framework
- 7.5.3.4. Reimbursement scenario
- 7.5.3.5. Canada Tracheostomy Tubes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.4. Mexico
- 7.5.4.1. Key Country Dynamics
- 7.5.4.2. Competitive Scenario
- 7.5.4.3. Regulatory Framework
- 7.5.4.4. Reimbursement scenario
- 7.5.4.5. Mexico Tracheostomy Tubes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.5. Europe
- 7.5.6. Europe Tracheostomy Tubes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.7. UK
- 7.5.7.1. Key Country Dynamics
- 7.5.7.2. Competitive Scenario
- 7.5.7.3. Regulatory Framework
- 7.5.7.4. Reimbursement scenario
- 7.5.7.5. UK Tracheostomy Tubes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.8. Germany
- 7.5.8.1. Key Country Dynamics
- 7.5.8.2. Competitive Scenario
- 7.5.8.3. Regulatory Framework
- 7.5.8.4. Reimbursement scenario
- 7.5.8.5. Germany Tracheostomy Tubes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.9. France
- 7.5.9.1. Key Country Dynamics
- 7.5.9.2. Competitive Scenario
- 7.5.9.3. Regulatory Framework
- 7.5.9.4. Reimbursement scenario
- 7.5.9.5. France Tracheostomy Tubes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.10. Italy
- 7.5.10.1. Key Country Dynamics
- 7.5.10.2. Competitive Scenario
- 7.5.10.3. Regulatory Framework
- 7.5.10.4. Reimbursement scenario
- 7.5.10.5. Italy Tracheostomy Tubes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.11. Spain
- 7.5.11.1. Key Country Dynamics
- 7.5.11.2. Competitive Scenario
- 7.5.11.3. Regulatory Framework
- 7.5.11.4. Reimbursement scenario
- 7.5.11.5. Spain Tracheostomy Tubes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.12. Denmark
- 7.5.12.1. Key Country Dynamics
- 7.5.12.2. Competitive Scenario
- 7.5.12.3. Regulatory Framework
- 7.5.12.4. Reimbursement scenario
- 7.5.12.5. Denmark Tracheostomy Tubes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.13. Sweden
- 7.5.13.1. Key Country Dynamics
- 7.5.13.2. Competitive Scenario
- 7.5.13.3. Regulatory Framework
- 7.5.13.4. Reimbursement scenario
- 7.5.13.5. Sweden Tracheostomy Tubes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.14. Norway
- 7.5.14.1. Key Country Dynamics
- 7.5.14.2. Competitive Scenario
- 7.5.14.3. Regulatory Framework
- 7.5.14.4. Reimbursement scenario
- 7.5.14.5. Norway Tracheostomy Tubes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6. Asia Pacific
- 7.6.1. Asia Pacific Tracheostomy Tubes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.2. Japan
- 7.6.2.1. Key Country Dynamics
- 7.6.2.2. Competitive Scenario
- 7.6.2.3. Regulatory Framework
- 7.6.2.4. Reimbursement scenario
- 7.6.2.5. Japan Tracheostomy Tubes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.3. China
- 7.6.3.1. Key Country Dynamics
- 7.6.3.2. Competitive Scenario
- 7.6.3.3. Regulatory Framework
- 7.6.3.4. Reimbursement scenario
- 7.6.3.5. China Tracheostomy Tubes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.4. India
- 7.6.4.1. Key Country Dynamics
- 7.6.4.2. Competitive Scenario
- 7.6.4.3. Regulatory Framework
- 7.6.4.4. Reimbursement scenario
- 7.6.4.5. India Tracheostomy Tubes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.5. South Korea
- 7.6.5.1. Key Country Dynamics
- 7.6.5.2. Competitive Scenario
- 7.6.5.3. Regulatory Framework
- 7.6.5.4. Reimbursement scenario
- 7.6.5.5. South Korea Tracheostomy Tubes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.6. Australia
- 7.6.6.1. Key Country Dynamics
- 7.6.6.2. Competitive Scenario
- 7.6.6.3. Regulatory Framework
- 7.6.6.4. Reimbursement scenario
- 7.6.6.5. Australia Tracheostomy Tubes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.7. Thailand
- 7.6.7.1. Key Country Dynamics
- 7.6.7.2. Competitive Scenario
- 7.6.7.3. Regulatory Framework
- 7.6.7.4. Reimbursement scenario
- 7.6.7.5. Thailand Tracheostomy Tubes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.7. Latin America
- 7.7.1. Latin America Tracheostomy Tubes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.7.2. Brazil
- 7.7.2.1. Key Country Dynamics
- 7.7.2.2. Competitive Scenario
- 7.7.2.3. Regulatory Framework
- 7.7.2.4. Reimbursement scenario
- 7.7.2.5. Brazil Tracheostomy Tubes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.7.3. Argentina
- 7.7.3.1. Key Country Dynamics
- 7.7.3.2. Competitive Scenario
- 7.7.3.3. Regulatory Framework
- 7.7.3.4. Reimbursement scenario
- 7.7.3.5. Argentina Tracheostomy Tubes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.8. Middle East & Africa
- 7.8.1. Middle East & Africa Tracheostomy Tubes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.8.2. South Africa
- 7.8.2.1. Key Country Dynamics
- 7.8.2.2. Competitive Scenario
- 7.8.2.3. Regulatory Framework
- 7.8.2.4. Reimbursement scenario
- 7.8.2.5. South Africa Tracheostomy Tubes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.8.3. Saudi Arabia
- 7.8.3.1. Key Country Dynamics
- 7.8.3.2. Competitive Scenario
- 7.8.3.3. Regulatory Framework
- 7.8.3.4. Reimbursement scenario
- 7.8.3.5. Saudi Arabia Tracheostomy Tubes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.8.4. UAE
- 7.8.4.1. Key Country Dynamics
- 7.8.4.2. Competitive Scenario
- 7.8.4.3. Regulatory Framework
- 7.8.4.4. Reimbursement scenario
- 7.8.4.5. UAE Tracheostomy Tubes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.8.5. Kuwait
- 7.8.5.1. Key Country Dynamics
- 7.8.5.2. Competitive Scenario
- 7.8.5.3. Regulatory Framework
- 7.8.5.4. Reimbursement scenario
- 7.8.5.5. Kuwait Tracheostomy Tubes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
- 8.1. Market Participant Categorization
- 8.2. Key Company Profiles
- 8.2.1. Pulmodyne, Inc.
- 8.2.1.1. Company overview
- 8.2.1.2. Financial performance
- 8.2.1.3. Product benchmarking
- 8.2.1.4. Strategic initiatives
- 8.2.2. Smiths Group plc
- 8.2.2.1. Company overview
- 8.2.2.2. Financial performance
- 8.2.2.3. Product benchmarking
- 8.2.2.4. Strategic initiatives
- 8.2.3. Medtronic
- 8.2.3.1. Company overview
- 8.2.3.2. Financial performance
- 8.2.3.3. Product benchmarking
- 8.2.3.4. Strategic initiatives
- 8.2.4. TRACOE Medical GmbH
- 8.2.4.1. Company overview
- 8.2.4.2. Financial performance
- 8.2.4.3. Product benchmarking
- 8.2.4.4. Strategic initiatives
- 8.2.5. Teleflex, Inc.
- 8.2.5.1. Company overview
- 8.2.5.2. Financial performance
- 8.2.5.3. Product benchmarking
- 8.2.5.4. Strategic initiatives
- 8.2.6. TuoRen
- 8.2.6.1. Company overview
- 8.2.6.2. Financial performance
- 8.2.6.3. Product benchmarking
- 8.2.6.4. Strategic initiatives
- 8.2.7. ConvaTec Group
- 8.2.7.1. Company overview
- 8.2.7.2. Financial performance
- 8.2.7.3. Product benchmarking
- 8.2.7.4. Strategic initiatives
- 8.2.8. Boston Medical
- 8.2.8.1. Company overview
- 8.2.8.2. Financial performance
- 8.2.8.3. Product benchmarking
- 8.2.8.4. Strategic initiatives
- 8.2.9. Fisher & Paykel Healthcare Ltd.
- 8.2.9.1. Company overview
- 8.2.9.2. Financial performance
- 8.2.9.3. Product benchmarking
- 8.2.9.4. Strategic initiatives
- 8.2.10. Angioplast
- 8.2.10.1. Company overview
- 8.2.10.2. Financial performance
- 8.2.10.3. Product benchmarking
- 8.2.10.4. Strategic initiatives
- 8.2.11. ICU Medical
- 8.2.11.1. Company overview
- 8.2.11.2. Financial performance
- 8.2.11.3. Product benchmarking
- 8.2.11.4. Strategic initiatives